Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy

Abstract

Familial platelet disorder with propensity to myeloid malignancy (FPD/AML) is an autosomal dominant syndrome characterized by platelet abnormalities and a predisposition to myelodysplasia (MDS) and/or acute myeloid leukemia (AML). The disorder, caused by inherited mutations in RUNX1, is uncommon with only 14 pedigrees reported. We screened 10 families with a history of more than one first degree relative with MDS/AML for inherited mutations in RUNX1. Germ- line RUNX1 mutations were identified in 5 pedigrees with a 3:2 predominance of N-terminal mutations. Several affected members had normal platelet counts or platelet function, features not previously reported in FPD/AML. The median incidence of MDS/AML among carriers of RUNX1 mutation was 35%. Individual treatments varied but included hematopoietic stem cell transplantation from siblings before recognition of the inherited leukemogenic mutation. Transplantation was associated with a high incidence of complications including early relapse, failure of engraftment, and posttransplantation lymphoproliferative disorder. Given the small size of modern families and the clinical heterogeneity of this syndrome, the diagnosis of FPD/AML could be easily overlooked and may be more prevalent than previously recognized. Therefore, it would appear prudent to screen young patients with MDS/AML for RUNX1 mutation, before consideration of sibling hematopoietic stem cell transplantation.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2008-05-156745

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 242

Metadata

Authors
Owen, C. J., Toze, C. L., Koochin, A., Forrest, D. L., Smith, C. A., Stevens, J. M., Jackson, S. C., Poon, M.-C., Sinclair, G. D., Leber, B., Johnson, P. R. E., Macheta, A., Yin, J. A. L., Barnett, M. J., Lister, T. A., & Fitzgibbon, J.
Affiliations
  • BC Cancer Agency (CA)
  • Queen Mary University of London (GB)
  • University of Calgary (CA)
  • McMaster University (CA)
  • Western General Hospital (GB)
  • Furness General Hospital (GB)
  • Manchester Royal Infirmary (GB)
Venue
Blood
Published
2008-12-01
Volume
112
Issue
12
Pages
4639-4645
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1998480851
Cited by
242
References
23
Citations by year
2026: 2 · 2025: 7 · 2024: 10 · 2023: 10 · 2022: 11 · 2021: 15 · 2020: 22 · 2019: 23 · 2018: 11 · 2017: 27 · 2016: 22 · 2015: 15 · 2014: 9 · 2013: 11 · 2012: 15
FWCI
6.87
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Lady Tata Memorial Trust
  • Cancer Research UK
  • Tata Trusts
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Hematology › Blood disorders and treatments
Keywords
RUNX1 mutation, germline mutations, myelodysplastic syndrome, acute myeloid leukemia, platelet abnormalities, hematopoietic stem cell transplantation, post-transplant lymphoproliferative disorder, N-terminal mutation, hereditary cancer predisposition, mutation detection
MeSH terms
Contraindications, Adolescent, Adult, Aged, Blood Platelet Disorders, Child, DNA Mutational Analysis, Family, Female, Humans, Leukemia, Myeloid, Male, Middle Aged, Mutation, Pedigree, Hematopoietic Stem Cell Transplantation, Disease Progression, Core Binding Factor Alpha 2 Subunit, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. https://app.cochat.ai/papers/10.1182/blood-2008-05-156745
The paper
Owen, C. J., Toze, C. L., Koochin, A., Forrest, D. L., Smith, C. A., Stevens, J. M., Jackson, S. C., Poon, M.-C., Sinclair, G. D., Leber, B., Johnson, P. R. E., Macheta, A., Yin, J. A. L., Barnett, M. J., Lister, T. A., & Fitzgibbon, J. (2008). Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. https://doi.org/10.1182/blood-2008-05-156745

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.